Hematologists warn myeloma patients may lose CAR-T therapy funding

CAR-T therapy for myeloma patients has been covered in Poland, but hematologists warn patients could lose access to the treatment. For some patients, CAR-T is the most effective method enabling long-term remission. Doctors are calling for the reimbursement decision to be changed.